Literature DB >> 4615135

Myopathy caused by polymyxin E: functional disorder of the cell membrane.

M Vanhaeverbeek, M Ectors, L Vanhaelst, L Franken.   

Abstract

A myopathy caused by the activity of polymyxin E on the cell membrane was accompained by immunological manifestations. There were also disturbances of the central nervous system, contrasting with the absence of serious renal lesion.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4615135      PMCID： PMC1083650          DOI： 10.1136/jnnp.37.12.1343

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  14 in total

1.  Neuromuscular-blocking properties of various polypeptide antibiotics.

Authors:  R H ADAMSON; F N MARSHALL; J P LONG
Journal:  Proc Soc Exp Biol Med       Date:  1960-12

2.  The treatment of gram-negative bacillary infections with colistin. The toxicity and efficacy of large doses in forty-eight patients.

Authors:  F R FEKETY; P S NORMAN; L E CLUFF
Journal:  Ann Intern Med       Date:  1962-08       Impact factor: 25.391

3.  Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body.

Authors:  C M Kunin; A Bugg
Journal:  J Infect Dis       Date:  1971-10       Impact factor: 5.226

4.  Reversible respiratory paralysis associated with polymyxin therapy.

Authors:  L A Lindesmith; R D Baines; D B Bigelow; T L Petty
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

5.  Apnea during treatment with sodium colistimethate.

Authors:  A F Parisi; M H Kaplan
Journal:  JAMA       Date:  1965-10-18       Impact factor: 56.272

6.  [Curare-like action of antibiotics and potentiation of curares by antibiotics].

Authors:  M Weill; J P Gauthier-Lafaye; J Dupuis
Journal:  Therapie       Date:  1968 Jul-Aug       Impact factor: 2.070

7.  Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy.

Authors:  J Koch-Weser; V W Sidel; E B Federman; P Kanarek; D C Finer; A E Eaton
Journal:  Ann Intern Med       Date:  1970-06       Impact factor: 25.391

Review 8.  Molecular mechanisms of antibiotic action.

Authors:  W Carter; K S McCarty
Journal:  Ann Intern Med       Date:  1966-05       Impact factor: 25.391

9.  Respiratory arrest in myasthenia gravis with colistimethate therapy.

Authors:  D A Decker; R W Fincham
Journal:  Arch Neurol       Date:  1971-08

10.  An unusual case of neuromuscular blockade seen with therapeutic blood levels of colistin methanesulfonate (Coly-Mycin).

Authors:  G N Gold; A P Richardson
Journal:  Am J Med       Date:  1966-08       Impact factor: 4.965
View more
  2 in total

Review 1.  Toxicity of polymyxins: a systematic review of the evidence from old and recent studies.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

2.  Visualizing the Potential Impairment of Polymyxin B to Central Nervous System Through MR Susceptibility-Weighted Imaging.

Authors:  Ni Zhang; Lichong Zhu; Qiuhong Ouyang; Saisai Yue; Yichun Huang; Shuang Qu; Runwei Li; Yuanyuan Qiao; Man Xu; Fangfei He; Bin Zhao; Lai Wei; Xiaoai Wu; Peisen Zhang
Journal:  Front Pharmacol       Date:  2021-12-02       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.